As the pharmaceutical industry is toiling around the clock to destroy Democrats’ plan to allow Medicare to negotiate drug prices, a new report reveals that top industry players are raking in billions, padding their own pockets as they work to revoke benefits from millions of people. According to an analysis by Accountable.US, the five biggest pharmaceutical companies in the U.S.
BROADCASTING FOR INDEPENDENCE
